Company Filing History:
Years Active: 2017-2019
Title: Edurne San José Enériz: Innovator in Cancer Treatment
Introduction
Edurne San José Enériz is a prominent inventor based in Pamplona, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target DNA methyltransferases and histone methyltransferases. With a total of two patents to her name, her work is paving the way for innovative treatments in cancer and other diseases.
Latest Patents
Her latest patents include "Compounds as inhibitors of DNA methyltransferases" and "Compounds as dual inhibitors of histone methyltransferases and DNA methyltransferases." The first patent focuses on compounds that inhibit DNMT1, DNMT3A, and DNMT3B, which are crucial in the treatment and prevention of cancer, fibrosis, and immunomodulation. The second patent describes compounds that serve as anticancer agents and facilitate the generation of induced pluripotent stem cells.
Career Highlights
Throughout her career, Edurne has worked with notable organizations such as Fundación Para La Investigación Médica Aplicada. Her research has been instrumental in advancing the understanding of epigenetic regulation and its implications for therapeutic interventions.
Collaborations
Edurne has collaborated with esteemed colleagues, including Xabier Aguirre Ena and Julen Oyarzabal Santamarina, to further her research and innovations in the field.
Conclusion
Edurne San José Enériz is a trailblazer in the realm of medicinal chemistry, with her patents reflecting her commitment to improving cancer treatment. Her innovative work continues to inspire advancements in medical research and therapeutic applications.